1-9 of 9
Kamal Sharma, DO
Close
Sort by
Journal Articles

Final Results of a Phase 1-2 Study of Vorinostat (SAHA), Cladribine, and Rituximab (SCR) Relapsed B-Cell Non-Hodgkin’s Lymphoma and Previously Untreated Mantle Cell Lymphoma

Stephen Spurgeon, MD, Kamal Sharma, DO, David F. Claxton, MD, Christopher Ehmann, MD, Sara Shimko, BS, August Stewart, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Yiyi Chen, PhD, Motomi Mori, Jeffrey J. Pu, MD PhD, Elliot Epner, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1714.
https://doi.org/10.1182/blood.V124.21.1714.1714
Published: 2014
Journal Articles

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Kamal Sharma, DO, Violetta V. Leshchenko, PhD, Zainul Hasanali, BS, August Stuart, MS, Sara Shimko, BS, Stephen E Spurgeon, MD, Samir Parekh, MD, Elliot M Epner, MD Phd
Journal: Blood
Blood (2013) 122 (21): 3063.
https://doi.org/10.1182/blood.V122.21.3063.3063
Published: 2013
Journal Articles

Overcoming Ibrutinib Resitance In Relapsed Chronic Lymphocytic Leukemia

Kamal Sharma, DO, August Stuart, MS, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., MD
Journal: Blood
Blood (2013) 122 (21): 4891.
https://doi.org/10.1182/blood.V122.21.4891.4891
Published: 2013
Journal Articles

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Zainul Hasanali, BS, Kamal Sharma, DO, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2454.
https://doi.org/10.1182/blood.V120.21.2454.2454
Published: 2012
Journal Articles

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

August Stuart, BA, Kamal Sharma, DO, Sara Shimko, BS, Zainul Hasanali, BS, Elliot M Epner, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4619.
https://doi.org/10.1182/blood.V120.21.4619.4619
Published: 2012
Journal Articles

Vorinostat (SAHA), Cladribine, and Rituximab in Previously Untreated Mantle Cell Lymphoma: Updated Results From a Phase I/II Trial

Stephen E Spurgeon, MD, Kamal Sharma, DO, David F. Claxton, MD, Christopher W. Ehmann, MD, Carla Gallagher, PhD, Sara Shimko, BS, August Stewart, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Yiyi Chen, PhD, Elliot M Epner, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3675.
https://doi.org/10.1182/blood.V120.21.3675.3675
Published: 2012
Journal Articles

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Kamal Sharma, DO, Mithun Shah, MD, PhD, Zainul Hasanali, BA, Vikas Ghai, MD, Katie Broeg, BS, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., M.D.
Journal: Blood
Blood (2011) 118 (21): 2440.
https://doi.org/10.1182/blood.V118.21.2440.2440
Published: 2011
Journal Articles

Combination Therapy with Cladribine, Vorinostat, and Ofatumumab Achieves Complete Hematologic Remission in Refractory Classical Hairy Cell Leukemia

Vikas Ghai, MD, Kamal Sharma, DO, Kamal K.S. Abbi, Sara Shimko, BS, Elliot M Epner, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4622.
https://doi.org/10.1182/blood.V118.21.4622.4622
Published: 2011
Journal Articles

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Kamal Sharma, DO, John E. Janik, MD, Deirdre O’Mahony, MD, Donn Stewart, MD, Stefania Pittaluga, MD, Maryalice Stetler-Stevenson, MD, PhD, Elaine S. Jaffe, MD, Mark Raffeld, MD, Thomas A. Fleisher, MD, Cathryn C. Lee, NP, Nicole Urquhart, MD, Seth Steinberg, PhD, Thomas A. Waldmann, MD, John C. Morris, MD
Journal: Blood
Blood (2008) 112 (11): 2010.
https://doi.org/10.1182/blood.V112.11.2010.2010
Published: 2008